Tuesday, March 10, 2026 9:21:58 AM
Hi DFRAI, thanks - I really piled into this one over the last 3 months. This seems extremely de-risked and the opportunity is one of the most asymmetric that I have seen.
I hope you are right about the SAG and a positive outcome. I am still holding there and have fingers crossed. It is not the slam dunk that SLS is but I am hopeful. The biggest risk is that the company ignores the issues that EMA cares about in favor of the issues that they are most comfortable with.
I hope you are right about the SAG and a positive outcome. I am still holding there and have fingers crossed. It is not the slam dunk that SLS is but I am hopeful. The biggest risk is that the company ignores the issues that EMA cares about in favor of the issues that they are most comfortable with.
Recent SLS News
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/20/2026 09:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:08:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 08:06:12 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 03:34:33 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/30/2026 09:15:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:35:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:33:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:31:37 PM
- The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech • GlobeNewswire Inc. • 01/08/2026 05:08:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 01:30:35 PM
- Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge • GlobeNewswire Inc. • 12/24/2025 11:00:00 AM
- Sellas Life Sciences rises after reporting encouraging AML clinical results • IH Market News • 12/08/2025 03:26:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:07:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:13 PM
- Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (Canada) • 12/04/2025 05:20:00 PM
- Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (US) • 12/04/2025 05:20:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 01:45:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 09:08:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:01:58 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/27/2025 08:28:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2025 12:35:45 PM
